Literature DB >> 14314455

TOLBUTAMIDE TEST: A MISLEADING RESPONSE.

H C FORD, R E BAILEY.   

Abstract

Entities:  

Keywords:  DIAGNOSIS, DIFFERENTIAL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HYPERINSULINISM; HYPOGLYCEMIA; ISLET CELL TUMOR; PATHOLOGY; PHARMACOLOGY; TOLBUTAMIDE

Mesh：

Substances：

Year:  1965        PMID： 14314455      PMCID： PMC1845601          DOI： 10.1136/bmj.2.5457.343

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  PLASMA INSULIN IN ORGANIC HYPERINSULINISM: COMPARATIVE EFFECTS OF TOLBUTAMIDE, LEUCINE AND GLUCOSE.

Authors:  J C FLOYD; S S FAJANS; R F KNOPF; J W CONN
Journal:  J Clin Endocrinol Metab       Date:  1964-08       Impact factor: 5.958

2.  GLUCAGON DEFICIENCY AS A CAUSE OF HYPOGLYCEMIA.

Authors:  A GROLLMAN; W E MCCALEB; F N WHITE
Journal:  Metabolism       Date:  1964-08       Impact factor: 8.694

3.  Insulin assay in insulinomas.

Authors:  E SAMOLS; V MARKS
Journal:  Br Med J       Date:  1963-02-23

4.  Immunoassay of plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  Diabetes       Date:  1961 Sep-Oct       Impact factor: 9.461

5.  The diagnostic value of sodium tolbutamide in hypoglycemic states.

Authors:  S S FAJANS; J M SCHNEIDER; D E SCHTEINGART; J W CONN
Journal:  J Clin Endocrinol Metab       Date:  1961-04       Impact factor: 5.958

6.  Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.

Authors:  E F PFEIFFER; M PFEIFFER; H DITSCHUNEIT; C S AHN
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.